ALT: Altimmune, Inc.
Performance
ALT -48.42%
Watchlist
Select an item
Summary
ALT at a glance
ALT returned -48.42% over the past year and -27.78% a year over five years. Its worst drop in that year was -68.12%, smaller than 6% of stocks on Redstone, and its Sharpe ratio of -0.65 beats 9% of stocks on Redstone. It pays no dividends.
Current Drawdown
-65.70%
Rolling Volatility
56.68%
Actions
Metrics
Risk Indicators
Alpha-61.23%
Beta1.61x
Sharpe-0.65
Sortino-0.89
Omega0.89
Calmar-0.71
Martin-1.01
Profile
About ALT
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $412M
- Listed
- Oct 2005
- Employees
- 57
- Headquarters
- Gaithersburg, MD
- Website
- altimmune.com
Comparisons